Rating History for Esperion Therapeutics (ESPR) by Needham

More Stocks Rated by Needham | Latest Ratings for ESPR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/4/2026 Serge Belanger Downgrade Hold
(Buy)		 N/A
(N/A)		 3.11
(3.15)		 1.29% Details